Developmental Outcomes in Duarte Galactosemia

Area of Science:

• Genetics and Human Diseases
• Metabolic Disorders
• Newborn Screening

Background:

• Duarte galactosemia (DG) is a condition identified through newborn screening (NBS), but treatment guidelines remain unclear.
• The necessity of galactose dietary restriction for infants with DG has been debated for decades.
• This study addresses the lack of evidence regarding the long-term outcomes of DG.

Purpose of the Study:

• To determine if dietary galactose restriction impacts developmental outcomes in children with Duarte galactosemia.
• To provide evidence-based guidance for healthcare providers, families, and NBS professionals regarding DG management.

Main Methods:

• A cohort study involving 206 children with DG (case patients) and 144 controls (unaffected siblings).
• Retrospective parent surveys assessed infant diet; developmental outcomes were evaluated across 5 domains.
• Data were analyzed using independent discovery and validation sets to identify outcome associations with DG and milk exposure.

Main Results:

• No significant associations were found between Duarte galactosemia and any of the 73 developmental outcomes assessed.
• No significant differences in outcomes were observed between children with DG and controls.
• Infant milk exposure did not significantly correlate with developmental outcomes in children with DG.

Conclusions:

• The study demonstrates no significant differences in tested outcomes for children with DG compared to controls.
• Dietary management of galactose does not appear to influence developmental trajectories in children with DG.
• These findings provide a crucial foundation for evidence-based decision-making regarding DG treatment.